US Patent Issued to BIOGEN MA on April 15 for "O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors" (Massachusetts Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,728, issued on April 15, was assigned to BIOGEN MA INC. (Cambridge, Mass.).

"O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors" was invented by Nathan Genung (Charlestown, Mass.), Kevin M. Guckian (Northborough, Mass.), Jeffrey Vessels (Marlborough, Mass.), Lei Zhang (Westford, Mass.), Ryan Gianatassio (Everett, Mass.), Edward Yin Shiang Lin (Ashland, Mass.) and Zhili Xin (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds represented by formulas (IA) or (IB)or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of preparing and using the...